Physician profile
Anthony W Ware
NPI 1073516290
$2,991.54
in general payments reported to CMS, 2019-2025
11 companies · $2,044 in 2025
The $2,044 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.98 · 2020: $17.18 · 2021: $140 · 2022: $213 · 2023: $438 · 2024: $113 · 2025: $2,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,812 · Travel and Lodging: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,811.76 |
| Travel and Lodging | $782.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,748.07 | 2023-2025 | Blueprint Patient Specific Instrumentation, Mako, Pangea |
| Smith+Nephew, INC. | $655.59 | 2021-2025 | Journey II, Real Intelligence, Integra Movement Great Toe System |
| Southern Edge Orthopaedics, INC. | $263.61 | 2025 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2023 | Xarelto |
| Embody, INC. | $47.57 | 2022 | |
| Heron Therapeutics, INC. | $43.51 | 2025 | Zynrelef |
| Bioventus LLC | $26.98 | 2019 | |
| Moximed, INC | $22.98 | 2025 | Misha Knee System, Small, Left |
| Highridge Medical LLC | $20.61 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Pacira Pharmaceuticals Incorporated | $20.44 | 2025 | Iovera, Exparel |
| Zimmer Biomet Holdings, INC. | $17.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Ware listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.